Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade?
- 22 September 2014
- journal article
- Published by Wiley in International Journal of Urology
- Vol. 22 (1) , 132-133
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone‐releasing hormone therapy: prognostic significance?BJU International, 2010
- Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen-Deprivation TherapyEuropean Urology Supplements, 2008
- Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancerBJU International, 2008
- Redefining Clinically Significant Castration Levels in Patients With Prostate Cancer Receiving Continuous Androgen Deprivation TherapyJournal of Urology, 2007
- Reassessment of the definition of castrate levels of testosterone: implications for clinical decision makingUrology, 2000